MREO

MKT CAP:$49M

Mereo BioPharma Group PLC ADR

Market Cap

$49M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.31-$0.20 (-38.68%)

Jun 5, 2026

52W High $2.9452W Low $0.24

Company Details

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment ...

CEO

—

IPO Date

Apr 24, 2019

Website

www.mereobiopharma.com

Key Metrics TTM (GBP)

Revenue

£500.0K

-53.0% YoY

Net Income

-£36M

EPS (Diluted)

Free Cash Flow

-£27M

Revenue / Share

£0.00

Gross Margin

12.3%

Operating Margin

-7531.1%

Net Margin

-7139.7%

FCF Margin

-5391.1%

P/S

P/E

Earnings Reports

Q1 2026

May 12, 2026

£0

FY 2025

Mar 19, 2026

£500.0K

Q4 2025

Mar 19, 2026

£0-100.0%

Q3 2025

Nov 10, 2025

£0

Q2 2025

Aug 12, 2025

£500.0K

Revenue & Profitability (GBP)

Operating Cash Flow (GBP)

CapEx Spend (GBP)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (GBP)

OpEx Breakdown (GBP)

War Chest (GBP)

Shares Outstanding

Revenue Per Employee (GBP)

Revenue / Employee